BIREN DULAL: Open Payments
NPI 1508598079 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $35 |
| Corcept Therapeutics | 2 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: REPATHA, Korlym, Veozah, Cologuard Collection Kit, Dexcom G6 Transmitter, GVOKE HYPOPEN, Kerendia.
Industry payments across UT — which companies pay providers there.
